Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ulipristal acetate 10 mg impact on assisted reproduction outcomes in women with uterine fibroids
2014-000964-16Phase 3Completed
- Sponsor
- International Vaccine Institute
- Start
- Jul 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of ulipristal in Fibromyoma (LM), sponsored by International Vaccine Institute. Primary endpoint: Evolutionary gestation. Started Jul 2014; status: completed.
02
Drugs
ulipristal
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on 2014-000964-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000964-16.